126 related articles for article (PubMed ID: 38149695)
61. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
Matsuo K; Purushotham S; Jiang B; Mandelbaum RS; Takiuchi T; Liu Y; Roman LD
Am J Obstet Gynecol; 2019 Apr; 220(4):381.e1-381.e14. PubMed ID: 30582927
[TBL] [Abstract][Full Text] [Related]
62. Impact of pregnancy on non-metastatic breast cancer: a case control study.
Ezzat A; Raja MA; Berry J; Zwaan FE; Jamshed A; Rhydderch D; Rostom A; Bazarbashi S
Clin Oncol (R Coll Radiol); 1996; 8(6):367-70. PubMed ID: 8973852
[TBL] [Abstract][Full Text] [Related]
63. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
64. Survival Analysis of Cervical Cancer Patients: A Case Study of Bhutan.
Tshewang U; Satiracoo P; Lenbury Y
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2987-2993. PubMed ID: 34582671
[TBL] [Abstract][Full Text] [Related]
65. Extremes in body mass index affect overall survival in women with cervical cancer.
Clark LH; Jackson AL; Soo AE; Orrey DC; Gehrig PA; Kim KH
Gynecol Oncol; 2016 Jun; 141(3):497-500. PubMed ID: 27058838
[TBL] [Abstract][Full Text] [Related]
66. Laparoscopic versus open radical hysterectomy for stage IB2-IIB cervical cancer in the setting of neoadjuvant chemotherapy: a multi-institutional cohort study.
Ghezzi F; Cromi A; Ditto A; Vizza E; Malzoni M; Raspagliesi F; Uccella S; Corrado G; Cosentino F; Gotsch F; Martinelli F; Franchi M
Ann Surg Oncol; 2013 Jun; 20(6):2007-15. PubMed ID: 23224830
[TBL] [Abstract][Full Text] [Related]
67. Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB.
Zhou J; Chen Y; Xu X; Yan D; Lou H
Medicine (Baltimore); 2018 Jan; 97(2):e9323. PubMed ID: 29480826
[TBL] [Abstract][Full Text] [Related]
68. The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system.
Zyla RE; Gien LT; Vicus D; Olkhov-Mitsel E; Mirkovic J; Nofech-Mozes S; Djordjevic B; Parra-Herran C
Gynecol Oncol; 2020 Aug; 158(2):266-272. PubMed ID: 32471646
[TBL] [Abstract][Full Text] [Related]
69. Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract][Full Text] [Related]
70. Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Cancer Res Treat; 2020 Jan; 52(1):320-333. PubMed ID: 31401822
[TBL] [Abstract][Full Text] [Related]
71. Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy.
Senekjian EK; Hubby M; Bell DA; Anderson D; Herbst AL
Gynecol Oncol; 1986 Jun; 24(2):207-19. PubMed ID: 3086191
[TBL] [Abstract][Full Text] [Related]
72. Impact of Obesity on Clinical Outcomes in Patients with Early-Stage Cervical Cancer after Radical Hysterectomy with Pelvic Node Dissection.
Leetanaporn K; Hanprasertpong J
Oncol Res Treat; 2019; 42(11):553-563. PubMed ID: 31533125
[TBL] [Abstract][Full Text] [Related]
73. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S
Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186
[TBL] [Abstract][Full Text] [Related]
74. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
[TBL] [Abstract][Full Text] [Related]
75. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
76. Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
Lopez A; Rodriguez J; Estrada E; Aragona A; Chavez C; Amaro K; De Padua C; Borges Garnica A; Rendón G; Alméciga A; Serrano O; Scasso S; Laufer J; Greif D; Taranto F; Hoegl J; Calderaro di Ruggiero F; Pareja R
Int J Gynecol Cancer; 2021 Mar; 31(3):468-474. PubMed ID: 33649015
[TBL] [Abstract][Full Text] [Related]
77. Conservative management of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women.
Vlahos G; Rodolakis A; Diakomanolis E; Stefanidis K; Haidopoulos D; Abela K; Georgountzos V; Michalas S
Gynecol Obstet Invest; 2002; 54(2):78-81. PubMed ID: 12566748
[TBL] [Abstract][Full Text] [Related]
78. [Carcinoma of the uterine cervix during pregnancy].
Nowak-Markwitz E; Spaczyński M
Ginekol Pol; 2007 Sep; 78(9):727-32. PubMed ID: 18159829
[TBL] [Abstract][Full Text] [Related]
79. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
Anfinan N; Sait K
Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
[TBL] [Abstract][Full Text] [Related]
80. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
